Search for Clinical Trial Results

Sponsored By

Nasopharyngeal Carcinoma - 25 Studies Found

Status Study
Completed Study Name: Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Condition: Nasopharyngeal Carcinoma
Date: 2014-07-23
Not yet recruiting Study Name: Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2016-02-29
Interventions: Drug: Donafenib donafenib 200mg，bid Other Nam
Not yet recruiting Study Name: Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2011-08-15
Interventions:
  • Drug: Drug: Gemcitabine and cisplatin

Active, not recruiting Study Name: Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
Date: 2015-08-18
Completed Study Name: HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2015-08-12
Interventions: Procedure: interventional therapy nasopharyngeal carcinoma patients received HepaSphere interventional t
Completed Study Name: Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2008-06-12
Interventions:
  • Drug: Gemcitabine Intravenous

Recruiting Study Name: TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2016-09-21
Interventions:
  • Other: Drug: Taxol,cisplatin and capecitabine

Recruiting Study Name: The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Carcinoma
Date: 2015-05-28
Interventions:
  • Drug: Gemcitabine Experimental
Terminated Study Name: SOX as Salvage Treatment in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2011-07-26
Interventions: Drug: S-1 plus oxaliplatin S-1 60 mg BID at day 1-14 Oxaliplatin 100 mg/m2 at day 1 Frequence of cycles:
Completed Study Name: Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Date: 2011-10-04
Interventions:
  • Biological: DNAzyme targeting EBV-LMP1 (DZ1)

Next >>>